UW logo
Human Subjects Division (HSD)


eNews re: IRB Review, March 29, 2013

Mar 29, 2013 at 11:14am

Many HSD Changes Coming Soon!

HSD will be implementing many policy, procedure and form changes in the next six months. Many are planned improvements that are near completion. Other changes are required because of two recent federal audits of the UW IRB.

This end-of-the-month newsletter is out single most important way to communicate changes. We work hard to make it short, useful, and readable. You can read it here, on the announcements tab, or subscribe by sending an email to hsdinfo@uw.edu.


Minimal Risk Delays

HSD has many new staff, particularly among the Minimal Risk teams. Unfortunately, this has occurred at the time of year when we have the highest volume of Minimal Risk applications.

Turnaround time for many (but not all) Minimal Risk reviews is significantly longer right now. We greatly appreciate your patience while we continue hiring and training the new staff for this important area of our office.


Use of Synthetic Nucleic Acid Molecules with Humans

Effective: March 2, 2013

A new NIH policy now required the UW Institutional Biosafety Committee (IBC) to review for all studies involving the deliberate transfer into humans of synthetic nucleic acid molecules, or DNA or RNA derived from synthetic nucleic acid molecules that meet specific criteria. Three of our forms have minor changes. Read the full story here.


"Smart Form" Version of the Modification Form

HSD is converting the Modification Form to a PDF "smart" form. Read the details in our eNews.


Human Subjects Protection Training

Did you know that the UW Human Subjects Division doesn't require all researchers to obtain training in the protection of human subjects? The only requirements you have to follow of those of the funding agency. Read the details here.


Quick Tips from HSD

This quick tips highlights some good information on encryption. Read it in the eNews, or over on the "Quick Tips" tab.